BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 27, 2000
View Archived Issues
Cyclopamine interferes with genetic cancer signaling pathways
Read More
BPT and Pfizer join forces for pulmonary and systemic disease drug development
Read More
Oxford GlycoSciences makes considerable progress during first six months of 2000
Read More
Telik and Genaissance complete joint estrogen receptor research
Read More
HIV viral protein mutations focus potential vaccine development
Read More
Allergy researchers clarify IL-9-eosinophil interaction
Read More
Vivus seeks FDA approval to begin female sexual dysfunction trial
Read More
Immtech enters collaborative project for tuberculosis treatment
Read More
Zometa deemed approvable by FDA
Read More
Alexion acquires Prolifaron
Read More
Axcan licenses sulfated compounds for prevention of colorectal polyps
Read More
New COX-2 inhibitors from Uriach have high potency, selectivity and oral antiinflammatory activity
Read More
Plant-derived lignan demonstrates inotropic and antidiuretic effects
Read More
Merck Frosst describes efforts to obtain PDE4 inhibitors with improved properties
Read More
R.W. Johnson investigates impact of modifications to linezolid molecule on antibacterial activity
Read More
Novel drug target identified for hepatitis B
Read More
New alpha1/alpha2-adrenoceptor partial agonist S-19014 shows potential in migraine Rx
Read More
Portuguese investigators identify peripheral COMT inhibitor
Read More
FDA approves Trisenox for APL only three years after U.S. studies began
Read More
Novel class of bacterial DNA gyrase inhibitors presented at ICAAC by Pfizer
Read More
Novel compounds from American Home Products display high affinity for 5-HT1A receptors
Read More
AHP presents newest PTPase inhibitors with blood glucose-lowering activity
Read More
Benzimidazole FBPase inhibitors and their use in diabetes and related disorders
Read More
European patent issued to Pfizer covers new NPY antagonists
Read More
Thyroid receptor ligands particularly useful in the treatment of obesity
Read More
GABA-A receptor-selective compounds synthesized at Merck
Read More
New factor Xa inhibitors with therapeutic and diagnostic uses
Read More
Combinations with synergistic antitumor activity claimed by Pharmacia
Read More